Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin

Journal of Investigative Dermatology

Volumn 131, Issue 1, 2011, Pages 30-36

  Tiganescu, Ana ^a   Walker, Elizabeth A ^a   Hardy, Rowan S ^a   Mayes, Andrew E ^b   Stewart, Paul M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; FIBROBLAST; GENE CONTROL; HAIR FOLLICLE; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

EID: 78650268199     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.257     Document Type: Article

References (47)

1. Andersson AK, Atkinson SE, Khanolkar-Young S et al. (2007) Alteration of the cortisol-cortisone shuttle in leprosy type 1 reactions in leprosy patients in Hyderabad, India. Immunol Lett 15:72-5
2. Bocchi B, Kenouch S, Lamarre-Cliche M et al. (2004) Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertension. Hypertension 43:803-8
3. Bosset S, Bonnet-Duquennoy M, Barre P et al., (2003) Photo-ageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities. Br J Dermatol 149:826-35
4. Bujalska IJ, Walker EA, Tomlinson JW et al. (2002) 11b-Hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol. Endocr Res 28:449-61
5. Bujalska IJ, Durrani OM, Abbott J et al. (2007) Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat. J Endocrinol 192:279-88
6. Chang E, Yang J, Nagavarapu U et al. (2002a) Ageing and survival of cutaneous microvasculature. J Invest Dermatol 118:752-8
7. Chang HY, Chi JT, Dudoit S et al. (2002b) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 99:12877-82
8. Chipev CC, Simon M (2002) Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1. BMC Dermatol 2:13
9. Chung JH, Eun HC (2007) Angiogenesis in skin ageing and photoageing. J Dermatol 34:593-600
10. Cooper MS, Rabbitt EH, Goddard PE et al. (2002) Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17:979-86
11. Doyle Y, McKee M, Rechel B et al. (2009) Meeting the challenge of population ageing. BMJ 339:b3926
12. El-Domyati M, Attia S, Saleh F et al., (2002) Intrinsic ageing vs. photoageing: a comparative histopathological, immunohistochemical, and ultrastructur-al study of skin. Exp Dermatol 11:398-405
13. Farage MA, Miller KW, Berardesca E et al. (2009) Clinical implications of ageing skin: cutaneous disorders in the elderly. Am J Clin Dermatol 10:73-86
14. Farage MA, Miller KW, Elsner P et al. (2008) Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci 30:87-95
15. Fenske NA, Lober CW (1986) Structural and functional changes of normal ageing skin. J Am Acad Dermatol 15:571-85
16. Gambichler T, Matip R, Moussa G et al. (2006) In vivo data of epidermal thickness evaluated by optical coherence tomography: effects of age, gender, skin type, and anatomic site. J Dermatol Sci 44:145-52
17. Gebhardt C, Averbeck M, Diedenhofen N et al. (2009) Dermal hyaluronan is rapidly reduced by topical treatment with glucocorticoids. J Invest Dermatol 130:141-9
18. Grove GL, Kligman AM (1983) Age-associated changes in human epidermal cell renewal. J Gerontol 38:137-42
19. Hammami MM, Siiteri PK (1991) Regulation of 11beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab 73:326-34
20. Hardy R, Rabbitt EH, Filer A et al. (2008) Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis 67:1204-10
21. Harvell JD, Maibach HI (1994) Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermatol 194:1015-21
22. Hennebert O, Chalbot S, Alran S et al. (2007) Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol 104:326-33
23. Hewitt KN, Walker EA, Stewart PM (2005) Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydro-genase type 1 activity. Endocrinology 146:2539-43
24. Josse G, Rouvrais C, Mas A et al. (2009) A multitechnique evaluation of topical corticosteroid treatment. Skin Res Technol 15:35-9
25. Kao JS, Fluhr JW, Man MQ et al., (2003) Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 120:456-64
26. Kligman AM, Koblenzer C (1997) Demographics and psychological implications for the ageing population. Dermatol Clin 15:549-53
27. Kolbe L, Kligman AM, Schreiner V et al. (2001) Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 7:73-7
28. Lavker RM (1979) Structural alterations in exposed and unexposed aged skin. J Invest Dermatol 73:59-66
29. Li X, Lindquist S, Chen R et al. (2007) Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Int J Obes (Lond) 31:820-8
30. Lovell CR, Smolenski KA, Duance VC et al. (1987) Type I and III collagen content and fibre distribution in normal human skin during ageing. Br J Dermatol 117:419-28
31. Mills CM, Marks R (1993) Side effects of topical glucocorticoids. Curr Probl Dermatol 21:122-31
32. Moore JS, Monson JP, Kaltsas G et al. (1999) Modulation of 11b-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab 84:4172-7
33. Morgan SA, Sherlock M, Gathercole LL et al. (2009) 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes 58:2506-15
34. Nuutinen P, Autio P, Hurskainen T et al. (2001) Glucocorticoid action on skin collagen. Overview on clinical significance and consequences. J Eur Acad Dermatol Venereol 15:361-2
35. Oikarinen A, Autio P (1991) New aspects of the mechanism of corticosteroid-induced dermal atrophy. Clin Exp Dermatol 16:416-9
36. Onyimba CU, Vijapurapu N, Curnow SJ et al. (2006) Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye. J Endocrinol 190:483-93
37. Ricketts ML, Verhaeg JM, Bujalska I et al. (1998) Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 83:1325-35
38. Rinn JL, Bondre C, Gladstone HB et al. (2002) Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2:e119
39. Roupe G (2001) Skin of the ageing human being. Lakartidningen 98:1091-5
40. Schoepe S, Schäcke H, May E et al. (2006) Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 15:406-20
41. Schwartz RA, Janusz CA, Janniger CK (2006) Seborrheic dermatitis: an overview. Am Fam Physician 74:125-30
42. Swali A, Walker EA, Lavery GG et al. (2008) 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets. Diabetologia 51:2003-11
43. Tomlinson JW, Stewart PM (2007) Modulation of glucocorticoid action and the treatment of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 21:607-19
44. Tomlinson JW, Finney J, Gay C et al. (2008) Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes 57:2652-60
45. Tomlinson JW, Walker EA, Bujalska IJ et al. (2004) 11b-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-66
46. Uitto J (1997) Understanding premature skin ageing. N Engl J Med 337: 1463-5
47. Whitton JT, Everall JD (1973) The thickness of the epidermis. Br J Dermatol 89:467-76